You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
白雲山(00874.HK)分公司何濟公藥廠核減生產線
格隆匯 02-12 17:44

格隆匯2月12日丨白雲山(00874.HK)公佈,近日,公司分公司廣州白雲山醫藥集團股份有限公司白雲山何濟公制藥廠(以下簡稱"何濟公藥廠")收到廣東省藥品監督管理局核准簽發的《藥品生產許可證》,同意何濟公藥廠核減生產線。

藥品生產許可證副本變更情況:同意何濟公藥廠核減在生產地址"廣州市從化明珠工業園創業大道南 4 號(除 K1 棟)"生產車間"星洲製造部"中生產線"F棟生產線"。

F 棟生產線的生產範圍是中藥前處理及提取車間,本次核減該生產線原因是何濟公藥廠部分產能調整,有利於優化公司資源配置,繼續保持穩定的生產能力,滿足市場需求。本次獲得《藥品生產許可證》,對本公司當期業績無重大影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account